A Repurposed Drug Screen for Compounds Regulating Aquaporin 5 Stability in Lung Epithelial Cells
Aquaporin 5 (AQP5) is expressed in several cell types in the lung and regulates water transport, which contributes to barrier function during injury and the composition of glandular secretions. Reduced AQP5 expression is associated with barrier dysfunction during acute lung injury, and strategies to...
Main Authors: | John Villandre, Virginia White, Travis B. Lear, Yanwen Chen, Ferhan Tuncer, Emily Vaiz, Beyza Tuncer, Karina Lockwood, Dan Camarco, Yuan Liu, Bill B. Chen, John Evankovich |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.828643/full |
Similar Items
-
A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis
by: Yanwen Chen, et al.
Published: (2020-05-01) -
Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study
by: Jeong In Seo, et al.
Published: (2024-04-01) -
A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry
by: Yanwen Chen, et al.
Published: (2021-06-01) -
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
by: Xavier Thuru, et al.
Published: (2022-07-01) -
Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections
by: Janine N. Copp, et al.
Published: (2020-10-01)